Galera Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Galera Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four history and growth rate from Q4 2018 to Q2 2024.
  • Galera Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending June 30, 2024 was $633K, a 26.1% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Four, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $633K -$223K -26.1% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $633K Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $224K Dec 31, 2023 10-K 2024-03-28
Q3 2023 $857K Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $856K Jun 30, 2023 10-Q 2023-08-14
Q2 2020 $44K Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $44K Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $44K -$347K -88.7% Dec 31, 2019 10-K 2020-03-10
Q3 2019 $262K Sep 30, 2019 10-Q 2019-12-10
Q4 2018 $391K Dec 31, 2018 10-Q 2019-12-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.